🧠As we reach the last day of Alzheimer’s Month, Pharmidex reaffirms our commitment to supporting the fight against this devastating disease. 💜
September 30, 2024
Alzheimer’s not only impacts those diagnosed, but also their families, caregivers, and communities. At
Pharmidex, we stand with them, dedicated to offering our expertise in preclinical research to advance innovative treatments and therapies.
Our goal is to bring hope and progress to those facing the challenges of Alzheimer’s, working toward a future where the disease no longer robs us of our loved ones.
To the patients and families navigating this difficult journey, we are here to help, with science, compassion, and unwavering determination.

Together, we can drive change and find better solutions.
#AlzheimersMonth #FightAlzheimers #PharmidexResearch #HealthcareInnovation #DrugDiscovery #SupportingFamilies
At Pharmidex , we deliver high-quality LC-MS bioanalysis to support drug development across a wide range of analysis. Our experienced team supports preclinical, translational and clinical studies, providing accurate, reliable data under GLP and GCP to help drive confident decision-making. Learn more about our LC-MS capabilities: https://www.pharmidex.com/Discovery-Bioanalysis
Pharmidex offers high-quality Clinical Chemistry services delivering accurate, reliable data to support drug development. Our expert team and robust, quality-driven workflows enable trusted results that help accelerate decision-making and strengthen collaboration with pharma companies, CROs and academic partners. By working together, we support better science and more efficient drug development. 👉 Learn more: https://www.pharmidex.com/Clinical-chemistry
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
